Matches in Wikidata for { <http://www.wikidata.org/entity/Q64636119> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q64636119 description "clinical trial" @default.
- Q64636119 description "ensayu clínicu" @default.
- Q64636119 description "klinisch onderzoek" @default.
- Q64636119 description "клінічне випробування" @default.
- Q64636119 name "Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis" @default.
- Q64636119 type Item @default.
- Q64636119 label "Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis" @default.
- Q64636119 prefLabel "Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis" @default.
- Q64636119 P1050 Q64636119-840DB4AB-6C1C-4C04-A72C-703D24EAF41F @default.
- Q64636119 P1132 Q64636119-FF4EA2FD-A84F-4A7A-ABDE-2FD92AC4712B @default.
- Q64636119 P1476 Q64636119-05B40AD7-7FB8-482A-916E-447CFF89D381 @default.
- Q64636119 P17 Q64636119-0B7B1A68-EB46-412C-8DF2-4A81FAEA6986 @default.
- Q64636119 P17 Q64636119-28603C56-E9A4-44D5-AA98-2EFDC6466CEF @default.
- Q64636119 P17 Q64636119-2F97CD13-AD34-497D-B1BA-B28F941CE6FC @default.
- Q64636119 P17 Q64636119-30BF6D5C-E837-44C6-AB7B-7AE68F8681E7 @default.
- Q64636119 P17 Q64636119-57B52E19-EBCE-480D-8CE3-77172D4EEFB0 @default.
- Q64636119 P17 Q64636119-72C5FAB9-D31E-4C3E-B824-53537D332E4B @default.
- Q64636119 P17 Q64636119-8ABB000D-766D-45EE-9CE0-69F47C4ACAB6 @default.
- Q64636119 P17 Q64636119-AA900572-97A4-4C11-AC5D-8484CC2D4EEC @default.
- Q64636119 P17 Q64636119-BCE69118-D2D9-4D31-9BEF-78236418F70A @default.
- Q64636119 P17 Q64636119-C2B8D571-A013-4D9A-8FD1-0085DFF33D3B @default.
- Q64636119 P17 Q64636119-C78440A9-FFDC-44C5-93BC-C67C53A31661 @default.
- Q64636119 P17 Q64636119-C85956EF-7F3A-4AE7-8EA8-5366EF4D0FDD @default.
- Q64636119 P17 Q64636119-DF35BA65-BCC3-43AC-9E53-CD1A275491B8 @default.
- Q64636119 P2899 Q64636119-5351FDA9-E629-41CC-AC4B-A05DBA0DE5DB @default.
- Q64636119 P3098 Q64636119-57A81E76-D700-4362-9B55-DC5ACB10923C @default.
- Q64636119 P31 Q64636119-7837FF2B-78C2-479C-A802-3074D0713917 @default.
- Q64636119 P4135 Q64636119-FB878806-EA31-47AE-9783-F2FE835EBB5B @default.
- Q64636119 P580 Q64636119-7A2D2E6D-0ECF-4FA2-A879-0F846A82BE37 @default.
- Q64636119 P582 Q64636119-D3D923AE-949C-4668-918F-ECA9F1894845 @default.
- Q64636119 P6099 Q64636119-CD11F1CD-80BD-4632-900B-EBAD1464AAC2 @default.
- Q64636119 P8363 Q64636119-6350F1D6-2670-4569-8476-B577BF5BEC70 @default.
- Q64636119 P1050 Q1344835 @default.
- Q64636119 P1132 "+508" @default.
- Q64636119 P1476 "A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis" @default.
- Q64636119 P17 Q142 @default.
- Q64636119 P17 Q145 @default.
- Q64636119 P17 Q16 @default.
- Q64636119 P17 Q183 @default.
- Q64636119 P17 Q28 @default.
- Q64636119 P17 Q29 @default.
- Q64636119 P17 Q30 @default.
- Q64636119 P17 Q31 @default.
- Q64636119 P17 Q36 @default.
- Q64636119 P17 Q38 @default.
- Q64636119 P17 Q40 @default.
- Q64636119 P17 Q408 @default.
- Q64636119 P17 Q801 @default.
- Q64636119 P2899 "+18" @default.
- Q64636119 P3098 "NCT01785849" @default.
- Q64636119 P31 Q30612 @default.
- Q64636119 P4135 "+100" @default.
- Q64636119 P580 "2013-03-12T00:00:00Z" @default.
- Q64636119 P582 "2014-05-22T00:00:00Z" @default.
- Q64636119 P6099 Q42824827 @default.
- Q64636119 P8363 Q78089383 @default.